Reilly Financial Advisors’s Syndax Pharmaceuticals SNDX Stock Holding History

Reilly Financial Advisors’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,000	Closed	-$45K	–	1071
2021 Q1	$45K	Hold	2,000	–	–	﹤0.01%	381
2020 Q4	$44K	Hold	2,000	–	–	﹤0.01%	363
2020 Q3	$30K	Hold	2,000	–	–	﹤0.01%	382
2020 Q2	$30K	Hold	2,000	–	–	﹤0.01%	388
2020 Q1	$22K	Hold	2,000	–	–	﹤0.01%	412
2019 Q4	$18K	Hold	2,000	–	–	﹤0.01%	529
2019 Q3	$15K	Hold	2,000	–	–	﹤0.01%	567
2019 Q2	$19K	Hold	2,000	–	–	﹤0.01%	553
2019 Q1	$11K	Hold	2,000	–	–	﹤0.01%	669
2018 Q4	$9K	Buy	+2,000	New	+$11K	﹤0.01%	668

Other funds holding SNDX

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return